{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:21:27Z","timestamp":1770888087263,"version":"3.50.1"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,12]]},"DOI":"10.7759\/cureus.103448","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:37:53Z","timestamp":1770885473000},"source":"Crossref","is-referenced-by-count":0,"title":["Denture-Associated Candidiasis and Mucormycosis in Post-COVID-19 Older Adults Managed Through an Integrated Prosthodontic and Infectious Disease Approach: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Panagiota","family":"Chatzidou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Stratos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meira","family":"Chint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina","family":"Niakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Argirios","family":"Pissiotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savvas","family":"Kamalakidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdent.2023.104824","article-title":"General and orofacial symptoms associated with acute and long COVID in 80- and 90-year-old Swedish COVID-19 survivors","volume":"141","author":"Johansson AK","year":"2024","unstructured":"Johansson AK, Omar R, Lehmann S. General and orofacial symptoms associated with acute and long COVID in 80- and 90-year-old Swedish COVID-19 survivors. J Dent. 2024, 141:104824. 10.1016\/j.jdent.2023.104824","journal-title":"J Dent"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.61473","article-title":"Mucormycosis, the black fungus in the post-COVID-19 pandemic: a case report with review of literature","volume":"16","author":"Gandhewar AM","year":"2024","unstructured":"Gandhewar AM, Hande A, Akolkar S. Mucormycosis, the black fungus in the post-COVID-19 pandemic: a case report with review of literature. Cureus. 2024, 16:e61473. 10.7759\/cureus.61473","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2024-004127","article-title":"Retrospective study of patient characteristics and treatment for mucormycosis in post COVID-19 population in a tertiary care hospital","volume":"32","author":"Lakshmi JN","year":"2025","unstructured":"Lakshmi JN, Sai JB, Priya TG, Sushma T, Rukmini G, Mounica RV, Vardhan TV. Retrospective study of patient characteristics and treatment for mucormycosis in post COVID-19 population in a tertiary care hospital. European Journal of Hospital Pharmacy: Science and Practice. 2025, 32:334-37. 10.1136\/ejhpharm-2024-004127","journal-title":"European Journal of Hospital Pharmacy: Science and Practice"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2023.102365","article-title":"Fungal pathogens and COVID-19","volume":"75","author":"Singh \u0391","year":"2023","unstructured":"Singh \u0391, Kaur A, Chowdhary A. Fungal pathogens and COVID-19. Curr Opin Microbiol. 2023, 75:102365. 10.1016\/j.mib.2023.102365","journal-title":"Curr Opin Microbiol"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1007\/s00284-022-02824-6","article-title":"COVID-19-associated candidiasis: possible patho-mechanism, predisposing factors, and prevention strategies","volume":"79","author":"Ahmed N","year":"2022","unstructured":"Ahmed N, Mahmood MS, Ullah \u039cA, Araf Y, Rahaman TI, Moin AT, Hosen MJ. COVID-19-associated candidiasis: possible patho-mechanism, predisposing factors, and prevention strategies. Curr Microbiol. 2022, 79:article number 127.","journal-title":"Curr Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3290\/j.qi.b1491959","article-title":"Prevalence of candidiasis and oral candidiasis in COVID-19 patients: a cross-sectional pilot study from the patients' registry in a large health center","volume":"52","author":"Katz J","year":"2021","unstructured":"Katz J. Prevalence of candidiasis and oral candidiasis in COVID-19 patients: a cross-sectional pilot study from the patients' registry in a large health center. Quintessence Int. 2021, 52:714-8. 10.3290\/j.qi.b1491959","journal-title":"Quintessence Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X211048279","article-title":"Oral candidiasis caused by ciclesonide in a patient with COVID-19 pneumonia: a case report and literature review","volume":"9","author":"Ohashi N","year":"2021","unstructured":"Ohashi N, Ideta Y, Takeda A. Oral candidiasis caused by ciclesonide in a patient with COVID-19 pneumonia: a case report and literature review.  SAGE Open Med Case Rep. 2021, 9:2050313X211048279. 10.1177\/2050313X211048279","journal-title":"SAGE Open Med Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000515214","article-title":"Oral candidiasis and COVID-19 in users of removable dentures: is special oral care needed?","volume":"68","author":"Jer\u00f4nimo LS","year":"2022","unstructured":"Jer\u00f4nimo LS, Esteves Lima, RP, Suzuki TY, Discacciati JA, Bhering CL. Oral candidiasis and COVID-19 in users of removable dentures: is special oral care needed?. Gerontology. 2022, 68:80-5. 10.1159\/000515214","journal-title":"Gerontology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2021.1967699","article-title":"Mycotic infections - mucormycosis and oral candidiasis associated with Covid- 19: a significant and challenging association. Journal of oral microbiology","volume":"13","author":"Nambiar M","year":"2021","unstructured":"Nambiar M, Varma SR, Jaber M, Sreelatha SV, Thomas B, Nair AS. Mycotic infections - mucormycosis and oral candidiasis associated with Covid- 19: a significant and challenging association. Journal of oral microbiology. J Oral Microbio. 2021, 13:1967699. 10.1080\/20002297.2021.1967699","journal-title":"J Oral Microbio"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030846","article-title":"Oral candidiasis in adult and pediatric patients with COVID-19","volume":"11","author":"Pisano M","year":"2023","unstructured":"Pisano M, Romano A, Palo M, Serpico R, Contaldo M. Oral candidiasis in adult and pediatric patients with COVID-19. Biomedicines. 2023, 11:846. 10.3390\/biomedicines11030846","journal-title":"Biomedicines"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11030555","article-title":"Post-COVID-19 fungal infection in the aged population","volume":"11","author":"Chavda VP","year":"2023","unstructured":"Chavda VP, Mishra T, Kamaraj S, et al.. Post-COVID-19 fungal infection in the aged population. Vaccines (Basel). 2023, 11:555. 10.3390\/vaccines11030555","journal-title":"Vaccines (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13777","article-title":"Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients","volume":"24","author":"Bansal S","year":"2022","unstructured":"Bansal S, Rana A, Babras M, Yadav D, Jha P, Jain M, Sethi SK. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients. Transpl Infect Dis\r\n. 2022, 24:e13777. 10.1111\/tid.13777","journal-title":"Transpl Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.18203\/issn.2454-5929.ijohns20221056","article-title":"Factors contributing to poor outcome in COVID associated mucormycosis","volume":"8","author":"Sachdeva K","year":"2022","unstructured":"Sachdeva K, Tom SM, Raj LV, Saini S, Kabade MV, Shukla A. Factors contributing to poor outcome in COVID associated mucormycosis. International Journal of Otorhinolaryngology and Head and Neck Surgery. 2022, 8:453-8.","journal-title":"International Journal of Otorhinolaryngology and Head and Neck Surgery"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.4103\/ijp.ijp_839_21","article-title":"COVID-19-associated rhino-orbital-cerebral mucormycosis: a systematic review, meta-analysis, and meta-regression analysis","volume":"53","author":"Bhattacharyya A","year":"2021","unstructured":"Bhattacharyya A, Sarma P, Kaur H, et al.. COVID-19-associated rhino-orbital-cerebral mucormycosis: a systematic review, meta-analysis, and meta-regression analysis. Indian J Pharmacol. 2021, 53:499-510.","journal-title":"Indian J Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/ijdr.ijdr_1062_21","article-title":"Oral manifestations, risk factors and management strategies of COVID-19 associated mucormycosis in tertiary care hospital","volume":"34","author":"Goel P","year":"2023","unstructured":"Goel P, Kumar J, Rai A, Shakti P, Chouksey G. Oral manifestations, risk factors and management strategies of COVID-19 associated mucormycosis in tertiary care hospital. Indian J Dental Res. 2023, 34:155-8. 10.4103\/ijdr.ijdr_1062_21","journal-title":"Indian J Dental Res"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms12071356","article-title":"Oral microbiota alterations in subjects with SARS-CoV-2 displaying prevalence of the opportunistic fungal pathogen Candida albicans","volume":"12","author":"Alfaifi AA","year":"2024","unstructured":"Alfaifi AA, Holm JB, Wang TW, et al.. Oral microbiota alterations in subjects with SARS-CoV-2 displaying prevalence of the opportunistic fungal pathogen Candida albicans. Microorganisms. 2024, 12:1356.","journal-title":"Microorganisms"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1007\/s12663-023-01970-z","article-title":"Clinical, demographic, and oral presentations of COVID-19 associated mucormycosis from a tertiary care hospital in India: a cross-sectional study","volume":"22","author":"Somkuwar S","year":"2023","unstructured":"Somkuwar S, Vijayabharathi P, Galhotra V, et al.. Clinical, demographic, and oral presentations of COVID-19 associated mucormycosis from a tertiary care hospital in India: a cross-sectional study. Journal of Maxillofacial and Oral Surgery. 2023, 22:1130-8.","journal-title":"Journal of Maxillofacial and Oral Surgery"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1599_21","article-title":"Oral mucormycosis: an inevitable complication of COVID-19","volume":"11","author":"Kulkarni MD","year":"2022","unstructured":"Kulkarni MD, Gulati S, Gupta S, Sabharwal R, Rajguru JP, Baneerjee A. Oral mucormycosis: an inevitable complication of COVID-19. J Family Med Prim Care. 2022, 11:1672-6. 10.4103\/jfmpc.jfmpc_1599_21","journal-title":"J Family Med Prim Care"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.24425\/fmc.2021.137228","article-title":"Mucormycosis in head and neck area - the emerging health problem in COVID-19 pandemic. The perspective of a dental practitioner","volume":"61","author":"Pasternak M","year":"2021","unstructured":"Pasternak M, Olszanecki R. Mucormycosis in head and neck area - the emerging health problem in COVID-19 pandemic. The perspective of a dental practitioner. Folia Med Cracov. 2021, 61:117-27. 10.24425\/fmc.2021.137228","journal-title":"Folia Med Cracov"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/aobpla\/pls029","article-title":"Molecular breeding for the development of multiple disease resistance in Basmati rice","volume":"2012","author":"Singh A","year":"2012","unstructured":"Singh A, Singh V, Singh SP, et al.. Molecular breeding for the development of multiple disease resistance in Basmati rice. AoB Plants. 2012, 2012:pls029. 10.1093\/aobpla\/pls029","journal-title":"AoB Plants"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.3390\/jof8010044","article-title":"Dental and oral manifestations of COVID-19 related mucormycosis: diagnoses, management strategies and outcomes","volume":"8","author":"Janjua OS","year":"2021","unstructured":"Janjua OS, Shaikh MS, Fareed MA, Qureshi SM, Khan MI, Hashem D, Zafar MS. Dental and oral manifestations of COVID-19 related mucormycosis: diagnoses, management strategies and outcomes. J Fungi. 2021, 8:44.","journal-title":"J Fungi"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13338","article-title":"COVID-19-associated mucormycosis: an updated systematic review of literature","volume":"64","author":"Pal R","year":"2021","unstructured":"Pal R, Singh B, Bhadada S, Banerjee M, Bhogal RS, Hage N, Kumar A. COVID-19-associated mucormycosis: an updated systematic review of literature. Mycoses. 2021, 64:1452-9. 10.1111\/myc.13338","journal-title":"Mycoses"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7326\/acpjc-1995-123-3-a12","article-title":"The well-built clinical question: a key to evidence-based decisions","volume":"123","author":"Richardson S","year":"1995","unstructured":"Richardson S, Wilson C, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club. 1995, 123:A12-3. 10.7326\/acpjc-1995-123-3-a12","journal-title":"ACP J Club"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco AC","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al.. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018, 169:467-73. 10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"371","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 371:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2023.1180017","article-title":"Oral manifestations in hospital-admitted COVID-19 patients: a case control study","volume":"4","author":"Alhamed S","year":"2023","unstructured":"Alhamed S, Aljohani S. Oral manifestations in hospital-admitted COVID-19 patients: a case control study. Frontiers in Oral Health. 2023, 4:1180017. 10.3389\/froh.2023.1180017","journal-title":"Frontiers in Oral Health"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10040757","article-title":"Covid-19 symptomatic patients with oral lesions: clinical and histopathological study on 123 cases of the University Hospital Policlinic of Bari with a purpose of a new classification","volume":"10","author":"Favia G","year":"2021","unstructured":"Favia G, Tempesta A, Barile G, et al.. Covid-19 symptomatic patients with oral lesions: clinical and histopathological study on 123 cases of the University Hospital Policlinic of Bari with a purpose of a new classification. J Clin Med. 2021, 10:757.","journal-title":"J Clin Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154461","article-title":"Oral manifestations of COVID- 19: a cross-sectional study of their prevalence and association with disease severity","volume":"11","author":"Binmadi O","year":"2022","unstructured":"Binmadi O, Aljohani S, Alsharif M, Almazrooa SA, Sindi AM. Oral manifestations of COVID- 19: a cross-sectional study of their prevalence and association with disease severity. Journal of Clinical Medicine. 2022, 11:4461. 10.3390\/jcm11154461","journal-title":"Journal of Clinical Medicine"},{"key":"ref29","article-title":"Manifestations of diseases of the oral mucosa of patients in the Adjara Region during the Covid-19 pandemic","author":"Gogotishvili M","year":"2024","unstructured":"Gogotishvili M, Gogebashvili N, Bakradze M, Gorgiladze T, Japaridze F . Manifestations of diseases of the oral mucosa of patients in the Adjara Region during the Covid-19 pandemic. Georgian Medical News. 2024, 93-5.","journal-title":"Georgian Medical News"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa572","article-title":"The global emergence of the fungal pathogen Candida auris","volume":"72","author":"Sultan AS","year":"2021","unstructured":"Sultan AS, Vila T, Montelongo-Jauregui D, Jabra-Rizk MA. The global emergence of the fungal pathogen Candida auris. Clin Infect Dis. 2021, 72:178-9. 10.1093\/cid\/ciaa572","journal-title":"Clin Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2022.02.002","article-title":"Oral findings in patients with COVID-19 (in Spanish)","volume":"113","author":"Villarroel-Dorrego M","year":"2022","unstructured":"Villarroel-Dorrego M, Chac\u00f3n L, Rosas R. Oral findings in patients with COVID-19 (in Spanish). Actas Dermo-Sifiliogr\u00e1ficas. 2022, 113:T183-6. 10.1016\/j.ad.2022.02.002","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s12663-021-01679-x","article-title":"Oral manifestations of COVID-19 infection: an analytical cross-sectional study","volume":"21","author":"Ganesan A","year":"2022","unstructured":"Ganesan A, Kumar S, Kaur A, et al.. Oral manifestations of COVID-19 infection: an analytical cross-sectional study. J Maxillofac Oral Surg. 2022, 21:1326-35. 10.1007\/s12663-021-01679-x","journal-title":"J Maxillofac Oral Surg"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1186\/s43163-022-00203-3","article-title":"Oral mucosal lesions during SARS-CoV-2 infection: a case series and literature review","volume":"38","author":"Mahmoud MS","year":"2022","unstructured":"Mahmoud MS, Taha MS, Mansour OI. Oral mucosal lesions during SARS-CoV-2 infection: a case series and literature review. Egypt J Otolaryngol. 2022, 38:article number 18.","journal-title":"Egypt J Otolaryngol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14515","article-title":"Relationship between oral lesions and severe SARS-CoV-2 infection in intensive care unit patients","volume":"30","author":"Favia G","year":"2024","unstructured":"Favia G, Barile G, Tempesta A, et al.. Relationship between oral lesions and severe SARS-CoV-2 infection in intensive care unit patients. Oral Dis. 2024, 30:1296-303. 10.1111\/odi.14515","journal-title":"Oral Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/0022034520957289","article-title":"Oral manifestations in patients with COVID-19: a living systematic review","volume":"100","author":"Santos JA","year":"2021","unstructured":"Santos JA, Normando AG, Silva RL, et al.. Oral manifestations in patients with COVID-19: a living systematic review. J Dental Res. 2021, 100:141-54. 10.1177\/0022034520957289","journal-title":"J Dental Res"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47777","article-title":"Association between Candida albicans and COVID-19 in complete denture wearers: an observational study","volume":"15","author":"Ali O","year":"2023","unstructured":"Ali O, Alva B, Nagaral S, Patil R, Khan MU, Tiwari DA. Association between Candida albicans and COVID-19 in complete denture wearers: an observational study. Cureus. 2023, 15:e47777. 10.7759\/cureus.47777","journal-title":"Cureus"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1103226","article-title":"Multiple Candida strains causing oral infection in COVID-19 patients under corticosteroids and antibiotic therapy: An observational study","volume":"12","author":"Babamahmoodi F","year":"2022","unstructured":"Babamahmoodi F, Rezai S, Ahangarkani F, et al.. Multiple Candida strains causing oral infection in COVID-19 patients under corticosteroids and antibiotic therapy: An observational study. Front Cell Infect Microbiol. 2022, 12:1103226. 10.3389\/fcimb.2022.1103226","journal-title":"Front Cell Infect Microbiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0283295","article-title":"Antimicrobial effect of oral care gel containing hinokitiol and 4-isopropyl-3-methylphenol against intraoral pathogenic microorganisms","volume":"19","author":"Ohara H","year":"2023","unstructured":"Ohara H, Odanaka K, Shiine M, Hayasaka M. Antimicrobial effect of oral care gel containing hinokitiol and 4-isopropyl-3-methylphenol against intraoral pathogenic microorganisms. PLoS One. 2023, 19:e0283295. 10.1371\/journal.pone.0283295","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1346762","article-title":"Hospital antimicrobial stewardship: profiling the oral microbiome after exposure to COVID-19 and antibiotics","volume":"15","author":"Buendia P","year":"2024","unstructured":"Buendia P, Fernandez K, Raley C, Rahnavard A, Crandall KA, Castro JG. Hospital antimicrobial stewardship: profiling the oral microbiome after exposure to COVID-19 and antibiotics. Frontiers Microbiol. 2024, 15:1346762. 10.3389\/fmicb.2024.1346762","journal-title":"Frontiers Microbiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01296-8","article-title":"SARS-CoV-2 infection of the oral cavity and saliva","volume":"27","author":"Huang N","year":"2021","unstructured":"Huang N, P\u00e9rez P, Kato T, et al.. SARS-CoV-2 infection of the oral cavity and saliva. Nat Med. 2021, 27:892-903. 10.1038\/s41591-021-01296-8","journal-title":"Nat Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028327","article-title":"COVID-19 and its manifestations in the oral cavity: a systematic review","volume":"100","author":"Cuevas-Gonzalez MV","year":"2021","unstructured":"Cuevas-Gonzalez MV, Espinosa-Crist\u00f3bal LF, Donohue-Cornejo A, et al.. COVID-19 and its manifestations in the oral cavity: a systematic review. Medicine (Baltimore). 2021, 100:e28327. 10.1097\/MD.0000000000028327","journal-title":"Medicine (Baltimore)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.831744","article-title":"Long-term post-COVID-19 associated oral inflammatory sequelae","volume":"12","author":"Alfaifi A","year":"2022","unstructured":"Alfaifi A, Sultan AS, Montelongo-Jauregui D, Meiller TF, Jabra-Rizk MA. Long-term post-COVID-19 associated oral inflammatory sequelae. Front Cell Infect Microbiol. 2022, 12:831744. 10.3389\/fcimb.2022.831744","journal-title":"Front Cell Infect Microbiol"},{"key":"ref43","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11061442","article-title":"Oral myco- and bacteriobiota and yeast infections in mechanically ventilated COVID-19 patients","volume":"11","author":"Gregorczyk-Maga I","year":"2023","unstructured":"Gregorczyk-Maga I, Kania M, Sulik-Tyszka B, et al.. Oral myco- and bacteriobiota and yeast infections in mechanically ventilated COVID-19 patients. Microorganisms. 2023, 11:1442.","journal-title":"Microorganisms"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myae035","article-title":"Comparison of Candida colonization in intensive care unit patients with and without COVID- 19: first prospective cohort study from Turkey","volume":"62","author":"K\u00fc\u00e7\u00fckkaya IC","year":"2024","unstructured":"K\u00fc\u00e7\u00fckkaya IC, Orhun G, \u00c7a\u011fatay AA, et al.. Comparison of Candida colonization in intensive care unit patients with and without COVID- 19: first prospective cohort study from Turkey. Med Mycol. 2024, 62:myae035. 10.1093\/mmy\/myae035","journal-title":"Med Mycol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_1567_24","article-title":"Outcomes of surgical management in orbital cellulitis due to mucormycosis in patients recovered from COVID-19","volume":"73","author":"Lam J","year":"2025","unstructured":"Lam J, Kakarla P, Harika M, Sultana SS. Outcomes of surgical management in orbital cellulitis due to mucormycosis in patients recovered from COVID-19. Indian J Ophthalmol. 2025, 73:S472-77. 10.4103\/IJO.IJO_1567_24","journal-title":"Indian J Ophthalmol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000001956","article-title":"Assessment of species distribution and virulence factors of oral fungal carriage among hospitalized patients with COVID- 19: a case-control study","volume":"86","author":"Ramezanalipour Z","year":"2024","unstructured":"Ramezanalipour Z, Hashemi S, Ghazvini RD, et al.. Assessment of species distribution and virulence factors of oral fungal carriage among hospitalized patients with COVID- 19: a case-control study. Ann Med Surg (Lond). 2024, 86:2458-66. 10.1097\/MS9.0000000000001956","journal-title":"Ann Med Surg (Lond)"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20230845","article-title":"Evaluation of some immunological markers in co-infection of COVID-19 with thrush candidiasis","volume":"70","author":"Al-Kenani HQ","year":"2024","unstructured":"Al-Kenani HQ, Shaheed OM. Evaluation of some immunological markers in co-infection of COVID-19 with thrush candidiasis. Rev Assoc Med Bras (1992). 2024, 70:e20230845. 10.1590\/1806-9282.20230845","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52107-w","article-title":"Cryo-EM structures of Candida albicans Cdr1 reveal azole-substrate recognition and inhibitor blocking mechanisms","volume":"15","author":"Peng Y","year":"2024","unstructured":"Peng Y, Lu Y, Sun H, et al.. Cryo-EM structures of Candida albicans Cdr1 reveal azole-substrate recognition and inhibitor blocking mechanisms. Nat Commun. 2024, 15:7722. 10.1038\/s41467-024-52107-w","journal-title":"Nat Commun"},{"key":"ref49","doi-asserted-by":"crossref","DOI":"10.1007\/s12070-021-02807-2","article-title":"Epidemiology, clinical features and management of rhino orbital mucormycosis in post COVID 19 patients","volume":"74","author":"Desai EJ","year":"2022","unstructured":"Desai EJ, Pandya A, Upadhya I, Patel T, Banerjee S, Jain V. Epidemiology, clinical features and management of rhino orbital mucormycosis in post COVID 19 patients. Indian Journal of Otolaryngology and Head and Neck Surgery. 2022, 74:103-7.","journal-title":"Indian Journal of Otolaryngology and Head and Neck Surgery"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s12663-021-01532-1","article-title":"SARS-CoV-2, uncontrolled diabetes and corticosteroids - an unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis","volume":"20","author":"Moorthy A","year":"2021","unstructured":"Moorthy A, Gaikwad R, Krishna S, et al.. SARS-CoV-2, uncontrolled diabetes and corticosteroids - an unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis. J Maxillofac Oral Surg. 2021, 20: 418-25. 10.1007\/s12663-021-01532-1","journal-title":"J Maxillofac Oral Surg"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.21.26205","article-title":"CT and MRI findings of invasive mucormycosis in the setting of COVID- 19: experience from a single center in India","volume":"217","author":"Joshi AR","year":"2021","unstructured":"Joshi AR, Muthe MM, Patankar SH, Athawale A, Achhapalia Y. CT and MRI findings of invasive mucormycosis in the setting of COVID- 19: experience from a single center in India. AJR Am J Roentgenol. 2021, 217:1431-2. 10.2214\/AJR.21.26205","journal-title":"AJR Am J Roentgenol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1155\/cjid\/4780569","article-title":"Craniofacial involvement of mucormycosis: a single-center experience of 57 cases from Shiraz, Iran","volume":"57","author":"Naddaffard D","year":"2025","unstructured":"Naddaffard D, Yousefi O, Farrokhi A, et al.. Craniofacial involvement of mucormycosis: a single-center experience of 57 cases from Shiraz, Iran . Can J Infect Dis Med Microbiol. 2025, 57:4780569. 10.1155\/cjid\/4780569","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.941488","article-title":"Prosthodontic rehabilitation's role in alleviating anxiety and depression in mucormycosis-induced maxillectomy patients post-COVID-19","volume":"29","author":"Sindi AS","year":"2023","unstructured":"Sindi AS, Kumar L, Verma A, et al.. Prosthodontic rehabilitation's role in alleviating anxiety and depression in mucormycosis-induced maxillectomy patients post-COVID-19. Med Sci Monit. 2023, 29:e941488. 10.12659\/MSM.941488","journal-title":"Med Sci Monit"},{"key":"ref54","article-title":"Recent advances in diagnostic approaches for mucormycosis","volume":"10","author":"Safiia J","year":"2024","unstructured":"Safiia J, D\u00edaz A, Alshaker H, et al.. Recent advances in diagnostic approaches for mucormycosis. J Fungi (Basel). 2024, 10:727.","journal-title":"J Fungi (Basel)"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-025-01829-8","article-title":"Steroid-responsive progressive subacute cerebellar ataxia: an unrecognized subtype of immune-mediated ataxia","volume":"24","author":"Choi EH","year":"2025","unstructured":"Choi EH, Park JH, Choi JY, Kim JS. Steroid-responsive progressive subacute cerebellar ataxia: an unrecognized subtype of immune-mediated ataxia. Cerebellum . 2025, 24:80. 10.1007\/s12311-025-01829-8","journal-title":"Cerebellum"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1984_24","article-title":"Risk factors for COVID-19-associated mucormycosis (CAM): a case-control study","volume":"14","author":"Sujiv A","year":"2025","unstructured":"Sujiv A, Aishwarya Lakshmi NR, Deshmukh PR, Tripathy JP, Khan MF, Thomas V. Risk factors for COVID-19-associated mucormycosis (CAM): a case-control study. J Family Med Prim Care. 2025, 14:2805-9. 10.4103\/jfmpc.jfmpc_1984_24","journal-title":"J Family Med Prim Care"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0322153","article-title":"Correction: Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India. PloS one, 20, e0322153","volume":"20","author":"Ponnaiah M","year":"2025","unstructured":"Ponnaiah M, Ganesan S, Bhatnagar T, et al.. Correction: Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India. PloS one, 20, e0322153. PLoS One. 2025, 20:e0322153. 10.1371\/journal.pone.0322153","journal-title":"PLoS One"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.22088\/cjim.16.2.239","article-title":"Mucormycosis in patients infected with the delta strain of COVID-19 virus, effective of some factors in the prevalence and patient prognosis in Shahid Beheshti Hospital, Kashan, central Iran","volume":"16","author":"Soleimani Z","year":"2025","unstructured":"Soleimani Z, Esalatmanesh K, Hooshyar H,  Rahimi H, Reisee M, Esalatmanesh R . Mucormycosis in patients infected with the delta strain of COVID-19 virus, effective of some factors in the prevalence and patient prognosis in Shahid Beheshti Hospital, Kashan, central Iran. Caspian J Intern Med. 2025, 16:239-45. 10.22088\/cjim.16.2.239","journal-title":"Caspian J Intern Med"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/myc.70110","article-title":"Clinical characteristics, radiological, and outcomes of mucormycosis: a 14-year retrospective study from southern China","volume":"68","author":"Liu","year":"2025","unstructured":"Liu, J., Yu, L., Ma, X. Clinical characteristics, radiological, and outcomes of mucormycosis: a 14-year retrospective study from southern China. Mycoses. 2025, 68:e70110. 10.1111\/myc.70110","journal-title":"Mycoses"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/myc.70108","article-title":"Aspergillosis and mucormycosis-associated hospitalizations, United States","volume":"68","author":"Rhee RJ","year":"2025","unstructured":"Rhee RJ, Edwards JA, Benedict K, Gold JA. Aspergillosis and mucormycosis-associated hospitalizations, United States. Mycoses. 2025, 68:e70108. 10.1111\/myc.70108","journal-title":"Mycoses"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.4103\/ojo.ojo_221_23","article-title":"An unusual case of corneal perforation secondary to frontal bone mucormycosis","volume":"18","author":"Anitha V","year":"2025","unstructured":"Anitha V, Velu M, Babu S, Rajesh A, Ravindran M. An unusual case of corneal perforation secondary to frontal bone mucormycosis. Oman J Ophthalmol. 2025, 18:73-6. 10.4103\/ojo.ojo_221_23","journal-title":"Oman J Ophthalmol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1155\/crip\/3227863","article-title":"Saksenaea oblongispora rhinosinusitis in advanced HIV: a rare and lethal mucormycosis","volume":"2025","author":"van der Westhuizen B","year":"2025","unstructured":"van der Westhuizen B, Budding L, Esterhuysen C, Potgieter S. Saksenaea oblongispora rhinosinusitis in advanced HIV: a rare and lethal mucormycosis. Case Rep Pathol. 2025, 2025:3227863. 10.1155\/crip\/3227863","journal-title":"Case Rep Pathol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1177\/20499361241253751","article-title":"Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges","volume":"11","author":"Tashiro M","year":"2024","unstructured":"Tashiro M, Takazono T, Izumikawa K. Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges. Ther Adv Infect Dis. 2024, 11:20499361241253751. 10.1177\/20499361241253751","journal-title":"Ther Adv Infect Dis"},{"key":"ref64","doi-asserted-by":"crossref","DOI":"10.3390\/jof9050592","article-title":"Clinical features and treatment progress of invasive mucormycosis in patients with hematological malignancies","volume":"9","author":"Yang N","year":"2023","unstructured":"Yang N, Zhang L, Feng S. Clinical features and treatment progress of invasive mucormycosis in patients with hematological malignancies. J Fungi. 2023, 9:592.","journal-title":"J Fungi"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.4103\/jips.jips_202_24","article-title":"Health-related quality of life after prosthodontic rehabilitation in patients with COVID-19-associated mucormycosis: A systematic review","volume":"25","author":"Chouksey G","year":"2025","unstructured":"Chouksey G, Choure R, Singhal K. Health-related quality of life after prosthodontic rehabilitation in patients with COVID-19-associated mucormycosis: A systematic review. J Indian Prosthodont Soc. 2025, 25:30-9. 10.4103\/jips.jips_202_24","journal-title":"J Indian Prosthodont Soc"},{"key":"ref66","doi-asserted-by":"crossref","DOI":"10.6026\/973206300211290","article-title":"Post Covid rhino-orbital cerebral mucormycosis among Indian patients","volume":"21","author":"Bharti R","year":"2025","unstructured":"Bharti R, Atreya K, Sunny K, Kumar D, Kumari B. Post Covid rhino-orbital cerebral mucormycosis among Indian patients. Bioinformation. 2025, 21:1290-4.","journal-title":"Bioinformation"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.83479","article-title":"A tragic tale of mucormycosis and COVID- 19: an observational study to identify predisposing risk factors and outcomes in a tertiary care centre in Central India","volume":"17","author":"Pandey V","year":"2025","unstructured":"Pandey V, Kubre J, Vatsalya T,  Ahirwar K, Mehrotra S. A tragic tale of mucormycosis and COVID- 19: an observational study to identify predisposing risk factors and outcomes in a tertiary care centre in Central India. Cureus. 2025, 17:e83479. 10.7759\/cureus.83479","journal-title":"Cureus"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.2174\/1871526523666230822154407","article-title":"Review on mucormycosis: pathogenesis, epidemiology, microbiology and diagnosis","volume":"24","author":"Sharma A","year":"2024","unstructured":"Sharma A, Alam MA, Dhoundiyal S, Sharma PK. Review on mucormycosis: pathogenesis, epidemiology, microbiology and diagnosis. Infect Disord Drug Targets. 2024, 24:e220823220209. 10.2174\/1871526523666230822154407","journal-title":"Infect Disord Drug Targets"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00562-25","article-title":"Key fungal coinfections: epidemiology, mechanisms of pathogenesis, and beyond","volume":"16","author":"Silva DL","year":"2025","unstructured":"Silva DL, Peres NT, Santos D. Key fungal coinfections: epidemiology, mechanisms of pathogenesis, and beyond. 2025, 16:e0056225. 10.1128\/mbio.00562-25"},{"key":"ref70","article-title":"Survival and prognostic factors in rhino-orbito-cerebral mucormycosis: a 3-year cohort study","volume":"15","author":"Zia Z","year":"2025","unstructured":"Zia Z, Sajadi J, Bazrafshan H, Khademi B, Janipour M. Survival and prognostic factors in rhino-orbito-cerebral mucormycosis: a 3-year cohort study. Scientific Reports. 2025, 15:16088.","journal-title":"Scientific Reports"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2025.2458786","article-title":"A novel mannan-specific chimeric antigen receptor M-CAR redirects T cells to interact with Candida spp. hyphae and Rhizopus oryzae spores","volume":"16","author":"Guimar\u00e3es G","year":"2025","unstructured":"Guimar\u00e3es G, de Campos Y, Machado M. A novel mannan-specific chimeric antigen receptor M-CAR redirects T cells to interact with Candida spp. hyphae and Rhizopus oryzae spores. Bioengineered. 2025, 16:2458786. 10.1080\/21655979.2025.2458786","journal-title":"Bioengineered"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2025.2528284","article-title":"Isolated orbital mucormycosis in the setting of COVID-19 pneumonia","volume":"38","author":"Nguyen KK","year":"2025","unstructured":"Nguyen KK, Ng J. Isolated orbital mucormycosis in the setting of COVID-19 pneumonia. Proc (Bayl Univ Med Cent). 2025, 38:955-7. 10.1080\/08998280.2025.2528284","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref73","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103115","article-title":"The diagnosis of mucormycosis by PCR in patients at risk: a systematic review and meta-analysis","volume":"81","author":"Brown L","year":"2025","unstructured":"Brown L, Tschiderer L, Alanio A, et al.. The diagnosis of mucormycosis by PCR in patients at risk: a systematic review and meta-analysis. eClinicalMedicine. 2025, 81:103115.","journal-title":"eClinicalMedicine"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-025-00966-2","article-title":"One-year patient survival after COVID-19-associated rhino-orbital-cerebral mucormycosis: a multicenter study","volume":"190","author":"Eshraghi B","year":"2025","unstructured":"Eshraghi B, Khademi B, Bahmani Kashkouli M, et al.. One-year patient survival after COVID-19-associated rhino-orbital-cerebral mucormycosis: a multicenter study. Mycopathologia. 2025, 190:63. 10.1007\/s11046-025-00966-2","journal-title":"Mycopathologia"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-025-05392-w","article-title":"The aftermath of the battle between Covid-19 and invasive fungal sinusitis: a long term prospective study","volume":"77","author":"Hameed N","year":"2025","unstructured":"Hameed N, Keshri A, Manogaran R, et al.. The aftermath of the battle between Covid-19 and invasive fungal sinusitis: a long term prospective study. Indian J Otolaryngol Head Neck Surg. 2025, 77:2733-9. 10.1007\/s12070-025-05392-w","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1007\/s10006-025-01419-2","article-title":"Adjunctive use of posaconazole, hyperbaric oxygen therapy, and methylene blue for COVID-19-associated mucormycosis","volume":"29","author":"Mohanty S","year":"2025","unstructured":"Mohanty S, Bansal N, Verma A. Adjunctive use of posaconazole, hyperbaric oxygen therapy, and methylene blue for COVID-19-associated mucormycosis. Oral Maxillofac Surg. 2025, 29:126. 10.1007\/s10006-025-01419-2","journal-title":"Oral Maxillofac Surg"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.30699\/ijp.2025.2044252.3371","article-title":"Clinical challenges and predictive risk factors for outcomes in COVID-19-associated mucormycosis","volume":"20","author":"Ahmadkhani F","year":"2025","unstructured":"Ahmadkhani F, Hashemi SJ, Daei Ghazvini RD, et al.. Clinical challenges and predictive risk factors for outcomes in COVID-19-associated mucormycosis. Iran J Pathol. 2025, 20:288-96. 10.30699\/ijp.2025.2044252.3371","journal-title":"Iran J Pathol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2025.100845","article-title":"Development and evaluation of real-time recombinase polymerase amplification assay for fast identification of Rhizopus arrhizus","volume":"55","author":"Hallur V","year":"2025","unstructured":"Hallur V, Sable M, Parida P, et al.. Development and evaluation of real-time recombinase polymerase amplification assay for fast identification of Rhizopus arrhizus. Indian J Med Microbiol. 2025, 55:100845. 10.1016\/j.ijmmb.2025.100845","journal-title":"Indian J Med Microbiol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-025-00937-7","article-title":"Molecular assays versus mycological methods for diagnosis of rhino orbital mucormycosis: analysis of 120 clinical specimens from COVID-19 patients","volume":"190","author":"Soltani S","year":"2025","unstructured":"Soltani S, Erami M, Ahmadikia K. Molecular assays versus mycological methods for diagnosis of rhino orbital mucormycosis: analysis of 120 clinical specimens from COVID-19 patients. Mycopathologia. 2025, 190:30. 10.1007\/s11046-025-00937-7","journal-title":"Mycopathologia"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.5c01999","article-title":"Targeting mucoricin: a novel approach for combating mucormycosis","volume":"10","author":"Tanwar M","year":"2025","unstructured":"Tanwar M, Singh A, Rathee M, Prasad CP, Singh TP, Sharma S, Sharma P. Targeting mucoricin: a novel approach for combating mucormycosis. ACS Omega. 2025, 10:29224-40. 10.1021\/acsomega.5c01999","journal-title":"ACS Omega"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.68873","article-title":"A case report on invasive mucormycosis involving the maxillary region, brain, and chest","volume":"16","author":"Yadav R","year":"2024","unstructured":"Yadav R, Parihar P, Yadav S, Yadav S. A case report on invasive mucormycosis involving the maxillary region, brain, and chest.  Cureus. 2024, 16:e68873. 10.7759\/cureus.68873","journal-title":"Cureus"},{"key":"ref82","doi-asserted-by":"crossref","DOI":"10.3390\/jof6040211","article-title":"COVID-19-associated candidiasis: an underestimated complication in critically ill patients","volume":"6","author":"Arastehfar A","year":"2020","unstructured":"Arastehfar A, Carvalho A, Nguyen M, Hedayati MT, Netea MG, Perlin DS, Hoenigi M. COVID-19-associated candidiasis: an underestimated complication in critically ill patients. J Fungi. 2020, 6:211.","journal-title":"J Fungi"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3201\/eid2611.203504","article-title":"Multidrug-resistant Candida auris infections in critically ill coronavirus disease patients, India, April-July","volume":"26","author":"Chowdhary A","year":"2020","unstructured":"Chowdhary A, Tarai B, Singh A, Sharma A. Multidrug-resistant Candida auris infections in critically ill coronavirus disease patients, India, April-July. Emerg Infect Dis. 2020, 26:2694-96. 10.3201\/eid2611.203504","journal-title":"Emerg Infect Dis"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001318","article-title":"On the emergence, spread and resistance of Candida auris: host, pathogen and environmental tipping points","volume":"70","author":"Chakrabarti A","year":"2021","unstructured":"Chakrabarti A, Sood P. On the emergence, spread and resistance of Candida auris: host, pathogen and environmental tipping points. J Med Microbiol. 2021, 70:001318. 10.1099\/jmm.0.001318","journal-title":"J Med Microbiol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.2.236","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes JA","year":"2000","unstructured":"Ribes JA, Vanover-Sams C, Baker D. Zygomycetes in human disease. Clin Microbiol Rev. 2000, 13:236-301. 10.1128\/CMR.13.2.236","journal-title":"Clin Microbiol Rev"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbr.2021.09.003","article-title":"The rise in cases of mucormycosis, candidiasis, and aspergillosis amidst COVID-19","volume":"38","author":"Ghosh A","year":"2021","unstructured":"Ghosh A, Sarkar A, Paul P, Patel P. The rise in cases of mucormycosis, candidiasis, and aspergillosis amidst COVID-19. Fungal Biol Rev. 2021, 38:67-91. 10.1016\/j.fbr.2021.09.003","journal-title":"Fungal Biol Rev"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e32834ab21e","article-title":"The emerging epidemiology of mould infections in developing countries","volume":"24","author":"Chakrabarti A","year":"2011","unstructured":"Chakrabarti A, Singh R. The emerging epidemiology of mould infections in developing countries. Curr Opin Infect Dis. 2011, 24:521-6. 10.1097\/QCO.0b013e32834ab21e","journal-title":"Curr Opin Infect Dis"},{"key":"ref88","article-title":"Is the frequency of candidemia increasing in COVID-19 patients receiving corticosteroids?","volume":"6","author":"Riche CVW","year":"2020","unstructured":"Riche CVW, Cassol R, Pasqualotto A. Is the frequency of candidemia increasing in COVID-19 patients receiving corticosteroids?. J Fungi. 2020, 6:286.","journal-title":"J Fungi"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.09.032","article-title":"Mucormycosis with orbital compartment syndrome in a patient with COVID-19","volume":"42","author":"Werthman-Ehrenreich A","year":"2021","unstructured":"Werthman-Ehrenreich A. Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med. 2021, 42:264.e5-e8. 10.1016\/j.ajem.2020.09.032","journal-title":"Am J Emerg Med"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10726","article-title":"Rhino-orbital mucormycosis associated with COVID-19","volume":"12","author":"Mehta S","year":"2020","unstructured":"Mehta S,  Pandey A . Rhino-orbital mucormycosis associated with COVID-19. Cureus. 2020, 12:e10726. 10.7759\/cureus.10726","journal-title":"Cureus"},{"key":"ref91","doi-asserted-by":"crossref","DOI":"10.4103\/0973-029X.203781","article-title":"Phenotypic switch: the enigmatic white-gray-opaque transition system of Candida albicans","volume":"21","author":"Bommanavar SB","year":"2017","unstructured":"Bommanavar SB, Gugwad S, Malik N. Phenotypic switch: the enigmatic white-gray-opaque transition system of Candida albicans. J Oral Maxillofac Pathol. 2017, 21:82-6.","journal-title":"J Oral Maxillofac Pathol"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1165_21","article-title":"Code mucor: guidelines for the diagnosis, staging, and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19","volume":"69","author":"Honavar S","year":"2021","unstructured":"Honavar S. Code mucor: guidelines for the diagnosis, staging, and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19. Indian J Ophthalmol. 2021, 69:1361-5. 10.4103\/ijo.IJO_1165_21","journal-title":"Indian J Ophthalmol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1111\/j.1470-9465.2004.00843.x","article-title":"Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment","volume":"10","author":"Prabhu RM","year":"2004","unstructured":"Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infec. 2004, 10:31-47. 10.1111\/j.1470-9465.2004.00843.x","journal-title":"Clin Microbiol Infec"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14066","article-title":"Oral candidiasis of COVID-19 patients: case report and review of evidence","volume":"20","author":"Riad A","year":"2021","unstructured":"Riad A, Gomaa E, Hockova B, Klugar M. Oral candidiasis of COVID-19 patients: case report and review of evidence. J Cosmet Dermatol. 2021, 20:1580-4. 10.1111\/jocd.14066","journal-title":"J Cosmet Dermatol"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis660","article-title":"Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011)","volume":"55","author":"Gamaletsou M","year":"2012","unstructured":"Gamaletsou M, Kontoyiannis P, Sipsas N, et al.. Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011). Clin Infect Dis. 2012, 55:1338-51. 10.1093\/cid\/cis660","journal-title":"Clin Infect Dis"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas P","year":"2018","unstructured":"Pappas P, Lionakis M, Arendrup M, Ostrosky-Zeichner L, Kullberg BJ . Invasive candidiasis. Nat Rev Dis Primers. 2018, 4:18026. 10.1038\/nrdp.2018.26","journal-title":"Nat Rev Dis Primers"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-019-0248-z","article-title":"Polymerase chain reaction versus blood culture to detect Candida species in high-risk patients with suspected invasive candidiasis: the MICAFEM study","volume":"8","author":"Nieto M","year":"2019","unstructured":"Nieto M, Robles J, Causse M, et al.. Polymerase chain reaction versus blood culture to detect Candida species in high-risk patients with suspected invasive candidiasis: the MICAFEM study. Infect Dis Ther. 2019, 8:429-44. 10.1007\/s40121-019-0248-z","journal-title":"Infect Dis Ther"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00053-10","article-title":"Histopathologic diagnosis of fungal infections in the 21st century","volume":"24","author":"Guarner J","year":"2011","unstructured":"Guarner J, Brandt ME. Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev. 2011, 24:247-80. 10.1128\/cmr.00053-10","journal-title":"Clin Microbiol Rev"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.3390\/jof4030097","article-title":"Treatment of invasive candidiasis: a narrative review","volume":"4","author":"Ben-Ami R","year":"2018","unstructured":"Ben-Ami R. Treatment of invasive candidiasis: a narrative review. J Fungi. 2018, 4:97. 10.3390\/jof4030097","journal-title":"J Fungi"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"Pappas P","year":"2004","unstructured":"Pappas P, Rex J, Sobel D, et al.. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004, 38:161-89. 10.1086\/380796","journal-title":"Clin Infect Dis"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/j.crbiot.2022.08.001","article-title":"The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review","volume":"4","author":"Akhtar N","year":"2022","unstructured":"Akhtar N, Wani AK, Tripathi SK, Prakash A, Mannan MA. The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review. Curr Res Biotechnol. 2022, 4:337-49. 10.1016\/j.crbiot.2022.08.001","journal-title":"Curr Res Biotechnol"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm: what we know so far","volume":"11","author":"Ragab D","year":"2020","unstructured":"Ragab D, Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 cytokine storm: what we know so far. Front Immunol. 2020, 11:1446. 10.3389\/fimmu.2020.01446","journal-title":"Front Immunol"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.15190\/d.2021.5","article-title":"High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections","volume":"9","author":"Bhatt K","year":"2021","unstructured":"Bhatt K, Agolli A, Patel MH, et al.. High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections. Discoveries (Craiova). 2021, 9:126. 10.15190\/d.2021.5","journal-title":"Discoveries (Craiova)"},{"key":"ref104","doi-asserted-by":"crossref","DOI":"10.4103\/jfmpc.jfmpc_1462_22","article-title":"Post-COVID mucormycosis in presentation of periodontal abscess","volume":"12","author":"Agarwal A","year":"2023","unstructured":"Agarwal A, Ratre M, Uikey G, Newaskar V. Post-COVID mucormycosis in presentation of periodontal abscess. J Fam Med Primary Care. 2023, 12:168-70.","journal-title":"J Fam Med Primary Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/457213-denture-associated-candidiasis-and-mucormycosis-in-post-covid-19-older-adults-managed-through-an-integrated-prosthodontic-and-infectious-disease-approach-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:37:57Z","timestamp":1770885477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/457213-denture-associated-candidiasis-and-mucormycosis-in-post-covid-19-older-adults-managed-through-an-integrated-prosthodontic-and-infectious-disease-approach-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":104,"URL":"https:\/\/doi.org\/10.7759\/cureus.103448","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,12]]}}}